Franck Thuny1, Daniel Lovric, Frédéric Schnell, Cyrille Bergerot, Laura Ernande, Vincent Cottin, Geneviève Derumeaux, Pierre Croisille. 1. From the Hospices Civils de Lyon, Université Claude Bernard Lyon, Lyon, France (F.T., D.L., F.S., C.B., L.E., V.C., G.D., P.C.); Centre d'Investigation Clinique de Lyon (CIC) & Service d'Explorations Fonctionnelles Cardiovasculaires, Groupement Hospitalier Est, Lyon, France (F.T., D.L., F.S., C.B., L.E., G.D.); CREATIS, CNRS UMR 5220, INSERM U1044, Université de Lyon, Lyon, France (F.T., P.C.); and Centre de Référence des Maladies Pulmonaires Rares, Centre de Compétence de l'hypertension Artérielle Pulmonaire, Hôpital Louis Pradel, 28 avenue Doyen Lepine, 69677 Bron, Lyon, France (V.C., G.D.).
Abstract
PURPOSE: To determine whether extracellular volume fraction (ECV) quantification at cardiac magnetic resonance (MR) imaging can demonstrate subclinical left ventricle (LV) abnormalities in a cohort of consecutive systemic sclerosis (SS) patients, and to investigate the relationship between ECV and diastolic and systolic LV function. MATERIALS AND METHODS: All subjects gave their written informed consent. The protocol was approved by the ethics committee. ECV quantification with cardiac MR imaging was prospectively performed in 33 consecutive SS patients with normal echocardiography results and no late gadolinium chelate enhancement at MR imaging. Left ventricular and atrial volumes and peak circumferential strain were measured at cardiac MR imaging. Diastolic function was assessed at echocardiography. The results were compared with those of 16 age-matched healthy control subjects by using Mann-Whitney and Kruskal-Wallis tests. RESULTS: SS patients had significantly higher global ECV (P < .001) and higher local ECV for all basal and midventricular LV segments. Global ECV significantly correlated with left atrial volume (P = .002) and with the grade of diastolic dysfunction (P = .016). The majority of SS patients (63%; 21 of 33 patients) had a high global ECV and a low global systolic circumferential strain. CONCLUSION: ECV quantification can identify LV abnormalities at an early stage in SS patients. These abnormalities may reflect increase in diffuse myocardial fibrosis and are associated with diastolic LV dysfunction.
PURPOSE: To determine whether extracellular volume fraction (ECV) quantification at cardiac magnetic resonance (MR) imaging can demonstrate subclinical left ventricle (LV) abnormalities in a cohort of consecutive systemic sclerosis (SS) patients, and to investigate the relationship between ECV and diastolic and systolic LV function. MATERIALS AND METHODS: All subjects gave their written informed consent. The protocol was approved by the ethics committee. ECV quantification with cardiac MR imaging was prospectively performed in 33 consecutive SS patients with normal echocardiography results and no late gadolinium chelate enhancement at MR imaging. Left ventricular and atrial volumes and peak circumferential strain were measured at cardiac MR imaging. Diastolic function was assessed at echocardiography. The results were compared with those of 16 age-matched healthy control subjects by using Mann-Whitney and Kruskal-Wallis tests. RESULTS: SS patients had significantly higher global ECV (P < .001) and higher local ECV for all basal and midventricular LV segments. Global ECV significantly correlated with left atrial volume (P = .002) and with the grade of diastolic dysfunction (P = .016). The majority of SS patients (63%; 21 of 33 patients) had a high global ECV and a low global systolic circumferential strain. CONCLUSION: ECV quantification can identify LV abnormalities at an early stage in SS patients. These abnormalities may reflect increase in diffuse myocardial fibrosis and are associated with diastolic LV dysfunction.
Authors: Francesco Sardanelli; Simone Schiaffino; Moreno Zanardo; Francesco Secchi; Paola Maria Cannaò; Federico Ambrogi; Giovanni Di Leo Journal: Eur Radiol Date: 2019-05-02 Impact factor: 5.315
Authors: Raluca B Dumitru; Lesley-Anne Bissell; Bara Erhayiem; Graham Fent; Ananth Kidambi; Peter Swoboda; Giuseppina Abignano; Helena Donica; Agata Burska; John P Greenwood; John Biglands; Francesco Del Galdo; Sven Plein; Maya H Buch Journal: Rheumatology (Oxford) Date: 2021-06-18 Impact factor: 7.580
Authors: Yin Yin Chen; Hong Yun; Hang Jin; De Hong Kong; Yu Liang Long; Cai Xia Fu; Shan Yang; Meng Su Zeng Journal: Int J Cardiovasc Imaging Date: 2017-03-17 Impact factor: 2.357
Authors: Heejung Kim; Sung-Jin Lee; Cynthia Davies-Venn; Jin Su Kim; Bo Yeun Yang; Zhengsheng Yao; Insook Kim; Chang H Paik; David A Bluemke Journal: Nucl Med Commun Date: 2016-02 Impact factor: 1.690
Authors: Daniel C Lee; Monique E Hinchcliff; Roberto Sarnari; Madeline M Stark; Jungwha Lee; Kimberly Koloms; Aileen Hoffmann; Mary Carns; Anjali Thakrar; Kathleen Aren; John Varga; Alejandro Aquino; James C Carr; Brandon C Benefield; Sanjiv J Shah Journal: J Scleroderma Relat Disord Date: 2018-04-12